Delving into the Latest Updates on Jilin Boda Weiye Pharmaceutical Co. Ltd. with Synapse

Overview

Tags

Digestive System Disorders

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Small molecule drug	1

Top 5 Target	Count

NF-κB(Nuclear factor NF-kappa-B complex)	1

考察中国健康受试者在空腹条件下单剂量口服吉林省博大伟业制药有限公司提供的溴吡斯的明片（受试制剂，T，60mg）与持证商Valeant Pharmaceuticals North America LLC的溴吡斯的明片（参比制剂，R，60mg）后的体内药代动力学特征，进行生物等效性评价。

[Translation]

The in vivo pharmacokinetic characteristics of pyridostigmine bromide tablets (test preparation, T, 60 mg) provided by Jilin Boda Weiye Pharmaceutical Co., Ltd. and pyridostigmine bromide tablets (reference preparation, R, 60 mg) from the licensed manufacturer Valeant Pharmaceuticals North America LLC were investigated in healthy Chinese subjects after a single oral dose under fasting conditions, and bioequivalence evaluation was performed.

Start Date22 Aug 2024

Sponsor / Collaborator

Jilin Boda Weiye Pharmaceutical Co. Ltd.

CTR20240187

/ CompletedNot Applicable

溴吡斯的明片在中国健康志愿者中空腹及餐后状态下的人体生物等效性试验

[Translation] Human bioequivalence study of pyridostigmine bromide tablets in Chinese healthy volunteers under fasting and fed conditions

考察中国健康受试者在空腹/餐后条件下单剂量口服吉林省博大伟业制药有限公司提供的溴吡斯的明片（受试制剂，T，60mg）与持证商Valeant Pharmaceuticals North America LLC的溴吡斯的明片（参比制剂，R，60mg）后的体内药代动力学特征，进行生物等效性评价。

[Translation]

The in vivo pharmacokinetic characteristics of pyridostigmine bromide tablets (test preparation, T, 60 mg) provided by Jilin Boda Weiye Pharmaceutical Co., Ltd. and pyridostigmine bromide tablets (reference preparation, R, 60 mg) from the licensed manufacturer Valeant Pharmaceuticals North America LLC were investigated in healthy Chinese subjects after a single oral dose under fasting/postprandial conditions, and bioequivalence evaluation was performed.

Start Date14 Mar 2024

Sponsor / Collaborator

Jilin Boda Weiye Pharmaceutical Co. Ltd.

CTR20231174

/ CompletedNot Applicable

评估受试制剂聚普瑞锌颗粒（规格：0.5 g:75 mg）与参比制剂（Promac®）（规格：0.5 g:75 mg）在健康成年受试者空腹和餐后状态下的单中心、随机、开放、单剂量、两周期、两序列、交叉生物等效性研究

[Translation] A single-center, randomized, open-label, single-dose, two-period, two-sequence, crossover bioequivalence study to evaluate the test formulation of polyprezinc granules (strength: 0.5 g: 75 mg) and the reference formulation (Promac®) (strength: 0.5 g: 75 mg) in healthy adult subjects in the fasting and fed state.

主要研究目的：研究空腹和餐后状态下单次口服受试制剂聚普瑞锌颗粒（规格：0.5 g:75 mg，持证商：吉林省博大伟业制药有限公司）与参比制剂聚普瑞锌颗粒（Promac®，规格：0.5 g:75 mg，持证商：ゼリア新薬工業株式会社）在健康受试者体内的药代动力学，评价空腹和餐后状态口服两种制剂的生物等效性。

[Translation]

Main research purpose: To study the single oral administration of the test preparation Polyprex zinc granules (specification: 0.5 g: 75 mg, license holder: Jilin Boda Weiye Pharmaceutical Co., Ltd.) and the reference preparation Juprex Pharmacokinetics of zinc granules (Promac®, specifications: 0.5 g: 75 mg, licensee: Seiko Shinsui Industrial Co., Ltd.) in healthy subjects, and evaluation of the bioequivalence of two oral formulations in fasting and postprandial states sex.

Start Date18 May 2023

Sponsor / Collaborator

Jilin Boda Weiye Pharmaceutical Co. Ltd.

100 Clinical Results associated with Jilin Boda Weiye Pharmaceutical Co. Ltd.

Login to view more data

0 Patents (Medical) associated with Jilin Boda Weiye Pharmaceutical Co. Ltd.

Login to view more data

100 Deals associated with Jilin Boda Weiye Pharmaceutical Co. Ltd.

Login to view more data

100 Translational Medicine associated with Jilin Boda Weiye Pharmaceutical Co. Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data